|
|
||||||||
J Thorac Cardiovasc Surg 2009;137:429-434
© 2009 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Department of Thoracic Surgery, Okayama Red Cross General Hospital, Okayama, Japan
b Department of Pathology, Okayama Red Cross General Hospital, Okayama, Japan
Received for publication February 24, 2008; revisions received June 5, 2008; accepted for publication July 4, 2008. * Address for reprints: Kentaroh Miyoshi, MD, Department of Thoracic Surgery, Okayama Red Cross General Hospital, 2–1-1 Aoe, Okayama 700–8607, Japan. (Email: kmiyosh{at}almond.ocn.ne.jp).
Objective: Intratumoral vessel invasion of non–small cell lung cancer is a readily available tumor-related factor that provides direct evidence of microscopic tumor invasion. We assessed the prognostic influence of intratumoral vessel invasion and its ability to provide a differential prediction of prognosis for completely resected pathologic stage I non–small cell lung cancer.
Methods: We analyzed 258 patients with non–small cell lung cancer who underwent complete resection between January of 1996 and December of 2005 and were diagnosed with pathologic stage I disease. In addition to the conventional staging factors, intratumoral vessel invasion in the primary lesion was histologically evaluated by both hematoxylin-eosin and elastic staining. We examined the significance of intratumoral vessel invasion in prognosis and compared the outcomes between patients with and without this factor with stage IA and IB disease, respectively.
Results: Intratumoral vessel invasion was found in 124 patients (48%). Five-year survival of patients with or without intratumoral vessel invasion was 74% and 93%, respectively. On multivariate analysis, intratumoral vessel invasion and pleural invasion were shown to be independent prognostic factors. Subgroup analyses suggested that patients with pathologic-stage IA with intratumoral vessel invasion and patients with pathologic-stage IB with both intratumoral vessel and pleural invasion had significantly worse prognosis than patients with the same pathologic stage without these factors.
Conclusion: The current study indicated that intratumoral vessel invasion and pleural invasion are independent prognostic factors. Intratumoral vessel invasion status can complement the size-dependent TNM staging system in pathologic stage I non–small cell lung cancer.
This article has been cited by other articles:
![]() |
C. Chen, F. Bao, H. Zheng, Y.-m. Zhou, M.-w. Bao, H.-k. Xie, G.-n. Jiang, J.-a. Ding, and W. Gao Local Extension at the Hilum Region Is Associated With Worse Long-Term Survival in Stage I Non-Small Cell Lung Cancers Ann. Thorac. Surg., February 1, 2012; 93(2): 389 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maeda, J. Yoshida, G. Ishii, T. Hishida, M. Nishimura, and K. Nagai Prognostic Impact of Histology on Early-Stage Non-small Cell Lung Cancer Chest, July 1, 2011; 140(1): 135 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Igai, N. Matsuura, S. Tarumi, S. S. Chang, N. Misaki, T. Go, S. Ishikawa, and H. Yokomise Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors Eur J Cardiothorac Surg, June 1, 2011; 39(6): 963 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maeda, J. Yoshida, G. Ishii, T. Hishida, M. Nishimura, and K. Nagai Poor Prognostic Factors in Patients With Stage IB Non-small Cell Lung Cancer According to the Seventh Edition TNM Classification Chest, April 1, 2011; 139(4): 855 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maeda, J. Yoshida, G. Ishii, T. Hishida, M. Nishimura, and K. Nagai Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients Thorax, December 1, 2010; 65(12): 1092 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maeda, J. Yoshida, G. Ishii, T. Hishida, K. Aokage, M. Nishimura, Y. Nishiwaki, and K. Nagai Long-term Survival and Risk Factors for Recurrence in Stage I Non-small Cell Lung Cancer Patients With Tumors up to 3 cm in Maximum Dimension Chest, August 1, 2010; 138(2): 357 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lin, M. Li, Z.-Y. Shen, L.-W. Xiong, X.-F. Pan, J.-F. Gen, G.-L. Bao, H.-F. Sha, J.-X. Feng, C.-Y. Ji, et al. Prognostic Impact of Vascular Endothelial Growth Factor-A and E-Cadherin Expression in Completely Resected Pathologic Stage I Non-Small Cell Lung Cancer Jpn. J. Clin. Oncol., July 1, 2010; 40(7): 670 - 676. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |